Literature DB >> 10376984

Systematic review of cancer treatment programmes in remote and rural areas.

N C Campbell1, L D Ritchie, J Cassidy, J Little.   

Abstract

In an attempt to ensure high quality cancer treatment for all patients in the UK, care is being centralized in specialist centres and units. For patients in outlying areas, however, access problems may adversely affect treatment. In an attempt to assess alternative methods of delivering cancer care, this paper reviews published evidence about programmes that have set out to provide oncology services in remote and rural areas in order to identify evidence of effectiveness and problems. Keyword and textword searches of on-line databases (MEDLINE, EMBASE, HEALTHSTAR and CINAHL) from 1978 to 1997 and manual searches of references were conducted. Fifteen papers reported evaluations of oncology outreach programmes, tele-oncology programmes and rural hospital initiatives. All studies were small and only two were controlled, so evidence was suggestive rather than conclusive. There were some indications that shared outreach care was safe and could make specialist care more accessible to outlying patients. Tele-oncology, by which some consultations are conducted using televideo, may be an acceptable adjunct. Larger and more methodologically robust studies are justified and should be conducted.

Entities:  

Mesh:

Year:  1999        PMID: 10376984      PMCID: PMC2362372          DOI: 10.1038/sj.bjc.6690498

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  The development of a provincial radiation oncology service: the first year report and its implications for future developments.

Authors:  D Byram; D Joseph; M Bulmer
Journal:  Australas Radiol       Date:  1996-08

Review 2.  Benefits from specialised cancer care.

Authors:  P Selby; C Gillis; R Haward
Journal:  Lancet       Date:  1996-08-03       Impact factor: 79.321

3.  "Best practice" in surgical management of breast cancer.

Authors:  J P Collins
Journal:  Med J Aust       Date:  1997-06-16       Impact factor: 7.738

4.  Differences in patterns of care of prostate cancer, New South Wales, 1991.

Authors:  M McCredie; J Bell; A Lee; J Rogers
Journal:  Aust N Z J Surg       Date:  1996-11

5.  Health outcomes of a community-based therapy program for children with cancer--a shared-management approach.

Authors:  C T Kisker; F Strayer; K Wong; W Clarke; R Strauss; R Tannous; R Janco; J Spevak
Journal:  Pediatrics       Date:  1980-12       Impact factor: 7.124

6.  Referral of lung cancer patients to university hospital cancer centers. A population-based study in two rural states.

Authors:  E R Greenberg; B Dain; D Freeman; J Yates; R Korson
Journal:  Cancer       Date:  1988-10-15       Impact factor: 6.860

7.  Colorectal cancer in a small rural hospital.

Authors:  J Callaghan
Journal:  Am J Surg       Date:  1990-03       Impact factor: 2.565

8.  Cost-effectiveness of a shared-management delivery system for the care of children with cancer.

Authors:  F Strayer; C T Kisker; C Fethke
Journal:  Pediatrics       Date:  1980-12       Impact factor: 7.124

9.  The hospital cancer program: its impact on care of the rural cancer patient.

Authors:  D E Smith; S Davis; L Polissar
Journal:  Am Surg       Date:  1979-11       Impact factor: 0.688

10.  Rural-urban differences in stage at diagnosis. Possible relationship to cancer screening.

Authors:  J M Liff; W H Chow; R S Greenberg
Journal:  Cancer       Date:  1991-03-01       Impact factor: 6.860

View more
  10 in total

1.  Centralisation of cancer services in rural areas has disadvantages.

Authors:  A G Baird; C M Donnelly; N T Miscampell; H D Wemyss
Journal:  BMJ       Date:  2000-03-11

2.  Teleoncology: current and future applications for improving cancer care globally.

Authors:  Ribhi Hazin; Ibrahim Qaddoumi
Journal:  Lancet Oncol       Date:  2010-02       Impact factor: 41.316

Review 3.  Rectal cancer surgery: volume-outcome analysis.

Authors:  Emmeline Nugent; Paul Neary
Journal:  Int J Colorectal Dis       Date:  2010-07-27       Impact factor: 2.571

4.  Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations.

Authors:  Amelie Boquoi; Veronika Rings; Annemarie Mohring; Ingrida Savickaite; Romans Zukovs; Judith Strapatsas; Kathrin Nachtkamp; Guido Kobbe; Ulrich Germing; Roland Fenk
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

5.  Cancer patients' concerns regarding access to cancer care: perceived impact of waiting times along the diagnosis and treatment journey.

Authors:  C Paul; M Carey; A Anderson; L Mackenzie; R Sanson-Fisher; R Courtney; T Clinton-McHarg
Journal:  Eur J Cancer Care (Engl)       Date:  2011-11-23       Impact factor: 2.520

6.  Access to specialist cancer care: is it equitable?

Authors:  E Pitchforth; E Russell; M Van der Pol
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

7.  Rural and urban differences in stage at diagnosis of colorectal and lung cancers.

Authors:  N C Campbell; A M Elliott; L Sharp; L D Ritchie; J Cassidy; J Little
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

8.  Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials.

Authors:  Joseph M Unger; Anna Moseley; Banu Symington; Mariana Chavez-MacGregor; Scott D Ramsey; Dawn L Hershman
Journal:  JAMA Netw Open       Date:  2018-08-03

9.  "When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.

Authors:  Joseph M Unger; Dawn L Hershman; Cathee Till; Lori M Minasian; Raymond U Osarogiagbon; Mark E Fleury; Riha Vaidya
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506

10.  Providing cancer services to remote and rural areas: consensus study.

Authors:  L Stevenson; N C Campbell; P A Kiehlmann
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.